Nippon Shinyaku Co., Ltd. Selects and Deploys the Symyx Technologies, Inc. (SMMX) Notebook by Accelrys Inc. (ACCL)
11/9/2011 10:01:50 AM
More...
|
Labopharm (DDS.TO), Nippon Shinyaku Co., Ltd. Reach Licensing Deal
4/8/2010 8:16:47 AM
More...
|
Pharmion Corporation (PHRM) And Nippon Shinyaku Co., Ltd. Announce Licensing Agreement For Vidaza(R) In Japan
11/21/2006 10:06:45 AM
More...
|
Bayer Yakuhin Ltd. To Transfer Baynas Marketing Rights To Nippon Shinyaku Co., Ltd.
4/24/2006 10:56:52 AM
More...
|
Nippon Shinyaku Co., Ltd. And Innovive Pharmaceuticals, Inc. Conclude Licensing Agreement For NS-187, Drug Candidate For Chronic Myelogenous Leukemia
1/6/2006 10:38:14 AM
More...
|
Hisamitsu Pharmaceutical , Nippon Shinyaku Co., Ltd. Conclude Joint Development Agreement For HFT-290 Cancer Pain Palliative Care Agent
10/19/2005 5:13:14 PM
More...
|
AEterna Zentaris (AEZS) Announces Decision To Continue Cetrorelix Development In Benign Prostate Hyperplasia In Japan
10/19/2005 5:13:03 PM
More...
|
Nippon Shinyaku Co., Ltd., Janssen Pharmaceutica Products, L.P. , Grunenthal GmbH To Collaborate In Development Of Oral Analgesic In Japan
10/19/2005 5:12:47 PM
More...
|
Cell Therapeutics, Inc. (CTIC) Release: TRISENOX(R) Now Available To APL Patients In Japan After Nippon Shinyaku Co., Ltd. Launch
10/19/2005 5:12:24 PM
More...
|
Nippon Shinyaku Co., Ltd. Receives Approval To Market TRISENOX(R) In Japan
10/19/2005 5:11:54 PM
More...
|
|